Periodicals
| ShowHide Related Items >><< - 01/17/23
- Catalent appoints Zayas as SVP, Operations, Biologics North America
- 01/09/23
- Avantor, Catalent enter multi-year supply agreement
- 01/05/23
- Acorda Therapeutics enters new long-term supply pact with Catalent on INBRIJA
- 01/05/23
- Catalent, Sarepta expand commercial collaboration with deal for DMD candidate
- 12/01/22
- Maravai Lifesciences announces plans for William Martin to become CEO in 2023
- 11/14/22
- Third Point buys TJX, exits Cenovus Energy in Q3
- 10/03/22
- Marvell CEO Carl Hull to switch roles, William Martin to succeed
- 09/14/22
- Danaher to separate Environmental & Applied Solutions unit into public company
- 01/24/23 Barclays
- Catalent price target lowered to $58 from $62 at Barclays
- 12/19/22 KeyBanc
- Catalent downgraded to Sector Weight from Overweight at KeyBanc
- 12/08/22 Baird
- Catalent short report doesn't raise new topics, says Baird
- 11/28/22 Morgan Stanley
- Catalent VAI update addresses Brussels shutdown concerns, says Morgan Stanley
- 01/25/23 Cowen
- Danaher price target lowered to $320 from $340 at Cowen
- 01/25/23 Baird
- Danaher price target lowered to $309 from $321 at Baird
- 01/24/23 Baird
- Danaher price target raised to $321 from $315 at Baird
- 01/24/23 Barclays
- Danaher price target raised to $290 from $277 at Barclays
- 11/01/22
- Catalent cuts FY23 revenue view to $4.625B-$4.875B from $4.975B-$5.225B
- 11/01/22
- Catalent reports Q1 adjusted EPS 34c, consensus 56c
- 08/29/22
- Catalent sees FY23 revenue $4.975B-$5.225B, consensus $5.26B
- 08/29/22
- Catalent reports Q4 EPS $1.19, consensus $1.15
- 01/24/23
- Danaher sees FY23 base business core revenue up high-single digits
- 01/24/23
- Danaher sees Q1 base business core revenue up mid-single digits
- 01/24/23
- Danaher reports Q4 adjusted EPS $2.87, consensus $2.51
- 01/09/23
- Danaher sees Q4 revenue up low-single digits, consensus 7.71B
- 01/13/23
- Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports
- 12/08/22
- Glasshouse Research short Catalent, cites 'accounting red flags'
- 08/11/22
- Repligen turned down bid from Catalent, Street Insider says
- 12/08/22
- What You Missed On Wall Street On Thursday
- 12/08/22
- What You Missed On Wall Street This Morning
- 11/28/22
- What You Missed On Wall Street On Monday
- 11/01/22
- What You Missed On Wall Street On Tuesday
- 01/24/23
- Fly Intel: Pre-market Movers
- 01/09/23
- Fly Intel: After-Hours Movers
- 10/20/22
- What You Missed On Wall Street On Thursday
- 10/20/22
- What You Missed On Wall Street This Morning
- 01/11/23
- Early notable gainers among liquid option names on January 11th
- 12/09/22
- Early notable gainers among liquid option names on December 9th
- 01/10/23
- Early notable gainers among liquid option names on January 10th
- 12/22/22
- Danaher call volume above normal and directionally bullish
|
On The Fly
| ShowHide Related Items >><< - 02/03/23
- Silvergate Capital falls -12.4%
- 02/02/23
- Silvergate Capital falls over 20% to $16.65 after DOJ fraud investigation report
- 02/02/23
- Silvergate Capital rises 29.4%
- 02/02/23
- Silvergate Capital rises 19.2%
- 01/10/23
- Amazon expands Buy with Prime service, introduces Reviews from Amazon
- 01/05/23
- Stitch Fix announces 20% reduction of salaried workforce
- 01/05/23
- Stitch Fix announces Spaulding to step down as CEO, Lake becomes interim CEO
- 12/19/22
- Stitch Fix announces Kofi Amoo-Gottfried joins board
- 12/27/22
- Janux submits IND app for JANX008 to FDA for CRC, NSCLC and RCC treatment
- 10/12/22
- Janux Therapeutics doses first patient in JANX007 trial
- 11/02/22
- Earthstone Energy raises Q4 production view to 98,000 -102,000 Boepd
- 10/11/22
- Earthstone Energy announces repurchase of 3M shares for $44M
- 09/14/22
- Earthstone Energy rises 8.3%
- 08/04/22
- Earthstone Energy sees FY22 CapEx $502M-$527M
- 02/02/23
- Dutch Bros CEO sells $6.0M in common stock
- 01/09/23
- Dutch Bros rises 9.3%
- 11/09/22
- Dutch Bros CEO: No good news on inflation
- 09/20/22
- Dutch Bros appoints Victoria Tullett as chief legal officer
- 01/06/23 Wells Fargo
- Stitch Fix upgraded to Equal Weight from Underweight at Wells Fargo
- 01/06/23 Wells Fargo
- Stitch Fix upgraded to Equal Weight from Underweight at Wells Fargo
- 12/20/22 JPMorgan
- Stitch Fix downgraded to Underweight from Neutral at JPMorgan
- 12/07/22 Evercore ISI
- Stitch Fix price target lowered to $6 from $7 at Evercore ISI
- 11/14/22 William Blair
- Janux Therapeutics initiated with an Outperform at William Blair
- 01/27/23 Wedbush
- Silvergate suspension of preferred dividends 'surprising,' says Wedbush
- 01/17/23 BTIG
- Silvergate Capital Q4 results highlight 'continued viability', says BTIG
- 01/09/23 Wedbush
- Silvergate Capital downgraded to Neutral from Outperform at Wedbush
- 01/06/23 Craig-Hallum
- Silvergate Capital downgraded to Hold from Buy at Craig-Hallum
- 01/26/23 Barclays
- Dutch Bros price target raised to $31 from $29 at Barclays
- 01/24/23 Wedbush
- Dutch Bros initiated with a Neutral at Wedbush
- 01/05/23 Baird
- Baird remains very bullish on long-term fundamentals at Dutch Bros
- 01/05/23 Barclays
- Dutch Bros price target lowered to $29 from $30 at Barclays
- 01/09/23 Mizuho
- Earthstone Energy initiated with a Neutral at Mizuho
- 07/06/22 RBC Capital
- Earthstone Energy downgraded to Sector Perform from Outperform at RBC Capital
- 07/06/22 RBC Capital
- Earthstone Energy downgraded to Sector Perform from Outperform at RBC Capital
- 06/29/22 Truist
- Earthstone Energy price target raised to $35 from $30 at Truist
- 01/17/23
- Silvergate Capital reports Q4 adjusted EPS 48c, consensus 81c
- 10/18/22
- Silvergate Capital reports Q3 EPS $1.28, consensus $1.38
- 12/06/22
- Stitch Fix cuts FY23 revenue view to $1.6B-$1.7B from $1.76B-$1.86B
- 12/06/22
- Stitch Fix sees Q2 revenue $410M-$420M, consensus $444.96M
- 12/06/22
- Stitch Fix reports Q1 EPS (50c), consensus (47c)
- 12/06/22
- Notable companies reporting after market close
- 11/10/22
- Janux Therapeutics reports Q3 EPS (40c), consensus (49c)
- 08/09/22
- Janux Therapeutics reports Q2 EPS (41c), consensus (37c)
- 11/02/22
- Earthstone Energy reports Q3 adjusted EPS $1.30, consensus $1.47
- 08/04/22
- Earthstone Energy reports Q2 adjusted EPS $1.29, consensus $1.25
- 11/09/22
- Dutch Bros sees 2022 revenue at least $725M, consensus $724.5M
- 11/09/22
- Dutch Bros reports Q3 EPS 9c, consensus 8c
- 08/10/22
- Dutch Bros backs FY22 revenue view at least $715M, consensus $713.11M
- 08/10/22
- Dutch Bros reports Q2 adjusted EPS 5c, consensus 7c
|
Periodicals
| ShowHide Related Items >><< - $520.87 /
-0.245 (-0.05%) - 12/05/22
- Ulta Beauty CEO: Consumer is loving what we are offering
- 12/01/22
- Ulta Beauty reports SSS up 14.6% y/y
- 10/07/22
- Tanger Factory announces first Ulta Beauty store opening in Rehoboth Beach
- 09/07/22
- Jeld-Wen appoints Halligan to board of directors
- $520.87 /
-0.245 (-0.05%) - 01/31/23 Jefferies
- Bath & Body Works price target raised to $52 from $45 at Jefferies
- 01/06/23 Wells Fargo
- Ulta Beauty downgraded to Underweight from Equal Weight at Wells Fargo
- 01/06/23 Wells Fargo
- Ulta Beauty downgraded to Underweight from Equal Weight at Wells Fargo
- 01/05/23 Argus
- Ulta Beauty price target raised to $530 from $455 at Argus
- $520.87 /
-0.245 (-0.05%) - 12/01/22
- Ulta Beauty raises FY22 EPS view to $22.60-$22.90 from $20.70-$21.20
- 12/01/22
- Ulta Beauty raises FY22 revenue view to $9.95B-$10.0B from $9.65B-$9.75B
- 12/01/22
- Ulta Beauty reports Q3 EPS $5.34, consensus $4.15
- 12/01/22
- Notable companies reporting after market close
- $520.87 /
-0.245 (-0.05%) - 01/12/23
- Conagra doesn't see need for 'big' price hikes in 2023, WSJ says
- $520.87 /
-0.245 (-0.05%) - 01/06/23
- What You Missed On Wall Street On Friday
- 01/06/23
- What You Missed On Wall Street This Morning
- 12/12/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/02/22
- What You Missed On Wall Street On Friday
- $520.87 /
-0.245 (-0.05%) - 12/01/22
- Ulta Beauty options imply 5.0% move in share price post-earnings
- 10/11/22
- Early notable gainers among liquid option names on October 11th
- 08/26/22
- Early notable gainers among liquid option names on August 26th
- 08/25/22
- Ulta Beauty options imply 5.6% move in share price post-earnings
|
Periodicals
|
Tesla stock is on a tear,… ShowHide Related Items >><< - 01/31/23
- Tesla sees capex of $6.0B-$8.0B in 2023 and $7B-9B in 2024 and 2025
- 01/31/23
- Tesla asked for documents on driver assist systems by DOJ
- 01/25/23
- Tesla extends afterhours gains, up over 5% at $152.45
- 01/25/23
- Tesla CEO says Dojo AI to be competitive with Nvidia at end of 2023
- 01/30/23 Bernstein
- Bernstein sees orders as 'most critical' to Tesla stock
- 01/30/23 Berenberg
- Tesla upgraded to Buy from Hold at Berenberg
- 01/26/23 Morgan Stanley
- Tesla FY23 earnings could bottom near $3 per share, says Morgan Stanley
- 01/26/23 Wedbush
- Tesla price target raised to $200 from $175 at Wedbush
- 01/25/23
- Tesla reports Q4 EPS $1.19, consensus $1.13
- 01/25/23
- Notable companies reporting after market close
- 10/19/22
- Tesla reports Q3 EPS $1.05, consensus 99c
- 10/19/22
- Notable companies reporting after market close
- 02/03/23
- Elon Musk prevails in shareholder lawsuit over 2018 tweet, WSJ says
- 02/03/23
- Tesla's sales of China-made EVs up 10% y/y in January, Reuters reports
- 02/01/23
- Tesla to ramp up Shanghai production, Reuters reports
- 01/31/23
- Tesla considering plant near new Mexico City airport, Reuters reports
- 09:29 Today
- Buy/Sell: Wall Street's top 10 stock calls this week
- 02/02/23
- What You Missed On Wall Street This Morning
- 01/31/23
- What You Missed On Wall Street On Tuesday
- 01/30/23
- What You Missed On Wall Street On Monday
- 02/03/23
- Early notable gainers among liquid option names on February 3rd
- 02/02/23
- Notable open interest changes for February 2nd
- 02/01/23
- Notable open interest changes for February 1st
- 01/31/23
- Notable open interest changes for January 31st
|
Periodicals
|
After a really bad year,… ShowHide Related Items >><< - 02/03/23
- Invitation Homes raises quarterly dividend 18% to 26c from 22c per share
- 01/30/23
- Invitation Homes CFO Ernie Freedman to step down
- 10/11/22
- Invitation Homes identifies 'limited damage' from Hurricane Ian
- 09/19/22
- Invitation Homes to replace Penn Entertainment in S&P 500 at open on 9/19
- $230.38 /
-6.565 (-2.77%) - 10/03/22
- Essex Property Trust CEO Michael Schall to retire
- 09/07/22
- Toll Brothers, Equity Residential team on Dallas-Fort Worth rental communities
- 08/31/22
- Equity Residential provides update on same store revenue growth
- $121.73 /
-4.485 (-3.55%) - 10/10/22
- Camden Property estimates $1.0M in expenses related to Hurricane Ian
- 09/30/22
- Camden Property says early reports indicate minor damage from Hurricane Ian
- 09/30/22
- Camden Property provides update on Hurricane Ian
- 01/17/23 Truist
- AvalonBay upgraded to Buy from Hold at Truist
- 01/04/23 Deutsche Bank
- Deutsche downgrades six REITs to Hold, urges caution into 2023
- 01/04/23 Deutsche Bank
- AvalonBay downgraded to Hold from Buy at Deutsche Bank
- 12/16/22 JPMorgan
- AvalonBay downgraded to Underweight from Neutral at JPMorgan
- $230.38 /
-6.565 (-2.77%) - 01/17/23 Truist
- Essex Property Trust price target raised to $250 from $247 at Truist
- 01/03/23 SMBC Nikko
- Essex Property Trust downgraded to Neutral from Outperform at SMBC Nikko
- 12/16/22 JPMorgan
- Essex Property Trust downgraded to Neutral from Overweight at JPMorgan
- 12/15/22 UBS
- Essex Property Trust initiated with a Neutral at UBS
- $121.73 /
-4.485 (-3.55%) - 02/03/23 Piper Sandler
- Camden Property downgraded on 'market drag' at Piper Sandler
- 02/02/23 Piper Sandler
- Camden Property downgraded to Neutral from Overweight at Piper Sandler
- 01/10/23 Mizuho
- Camden Property upgraded to Buy from Neutral at Mizuho
- 01/04/23 Deutsche Bank
- Camden Property price target lowered to $140 from $153 at Deutsche Bank
- 01/17/23 Truist
- Equity Residential upgraded to Buy from Hold at Truist
- 01/11/23 BTIG
- BTIG cuts Equity Residential to Neutral on underperformance in Apartment REITs
- 01/11/23 BTIG
- Equity Residential downgraded to Neutral from Buy at BTIG
- 01/09/23 Credit Suisse
- Equity Residential downgraded to Neutral from Outperform at Credit Suisse
- 01/09/23 Credit Suisse
- Invitation Homes downgraded to Neutral from Outperform at Credit Suisse
- 01/04/23 Deutsche Bank
- Invitation Homes downgraded to Hold from Buy at Deutsche Bank
- 01/03/23 Jefferies
- Invitation Homes downgraded to Hold at Jefferies on macro concerns
- 10/26/22
- Invitation Homes cuts FY22 core FFO view to $1.63-$1.67 from $1.66-$1.72
- 10/26/22
- Invitation Homes reports Q3 core FFO 42c, consensus 43c
- $230.38 /
-6.565 (-2.77%) - 10/26/22
- Essex Property Trust sees FY22 core FFO $14.42-$14.52, consensus $14.50
- 10/26/22
- Essex Property Trust reports Q3 core FFO $3.69, consensus $3.68
- 10/25/22
- Equity Residential sees FY22 normalized FFO $3.52-$3.54
- 10/25/22
- Equity Residential reports Q3 normalized FFO 92c, consensus 91c
- $121.73 /
-4.485 (-3.55%) - 02/02/23
- Camden Property sees Q1 FFO $1.63-$1.67, consensus $1.75
- 02/02/23
- Camden Property sees FY23 FFO $6.70-$7.00, consensus $7.17
- 02/02/23
- Camden Property reports Q4 FFO $1.74, consensus $1.74
- 10/27/22
- Camden Property see FY22 FFO $6.57-$6.61, consensus $6.63
- 11/03/22
- AvalonBay cuts FY22 core FFO view to $9.74-$9.84 from $9.76-$9.96
- 11/03/22
- AvalonBay sees Q4 core FFO $2.55-$2.65
- 11/03/22
- AvalonBay Communities reports Q3 core FFO $2.50, consensus $2.53
|
Periodicals
| ShowHide Related Items >><< - 01/18/23
- Linde shareholders approve proposal to delist from Frankfurt Stock Exchange
- 11/10/22
- Linde Engineering, Vision Energy sign cooperation agreement
- 11/08/22
- Great Lakes Clean Hydrogen Partnership moves forward with DOE application
- 10/31/22
- SLB and Linde collaborate on carbon capture and sequestration
- 01/10/23 Morgan Stanley
- Air Products downgraded to Equal Weight from Overweight at Morgan Stanley
- 12/15/22 Citi
- Linde price target raised to $402 from $322 at Citi
- 11/15/22 HSBC
- Linde price target lowered to $375 from $390 at HSBC
- 10/31/22 Deutsche Bank
- Linde price target raised to EUR 355 from EUR 350 at Deutsche Bank
- 01/03/23
- Russia freezes Linde assets worth around $500M, Reuters says
|
Periodicals
| ShowHide Related Items >><< - 02/01/23
- FDA revises EUA for Paxlovid to remove SARS-CoV-2 viral testing requirement
- 01/31/23
- Pfizer CEO: Our best days are still ahead of us
- 01/31/23
- Pfizer says incremental share repurchases 'not high priority at this point'
- 01/31/23
- Pfizer CFO says increasing investments behind launch products and pipeline
- 02/01/23 Barclays
- Pfizer price target lowered to $44 from $49 at Barclays
- 01/26/23 UBS
- UBS downgrades Pfizer, says COVID estimates need to drop
- 01/26/23 UBS
- Pfizer downgraded to Neutral from Buy at UBS
- 01/24/23 SVB Securities
- Biohaven initiated with an Outperform at SVB Securities
- 01/31/23
- Pfizer sees FY23 adjusted EPS $3.25-$3.45, consensus $4.44
- 01/31/23
- Pfizer reports Q4 adjusted EPS $1.14, consensus $1.05
- 01/30/23
- Notable companies reporting before tomorrow's open
- 02/01/23
- Novavax refuses to refund $700M for COVID shots never delivered, NY Times says
- 01/27/23
- FDA advisors recommend replacing original COVID-19 vaccine, CNBC reports
- 01/11/23
- Merck, Pfizer rebuff China's efforts to cut Covid drug prices, Bloomberg says
- 01/09/23
- Pfizer working with China partner to make Paxlovid available, Bloomberg reports
- 01/31/23
- What You Missed On Wall Street On Tuesday
- 01/31/23
- What You Missed On Wall Street This Morning
- 01/31/23
- Fly Intel: Pre-market Movers
- 01/26/23
- What You Missed On Wall Street On Thursday
- 01/31/23
- Unusually active option classes on open January 31st
- 01/11/23
- Largest borrow rate increases among liquid names
- 01/10/23
- Unusually active option classes on open January 10th
- 11/14/22
- Pfizer call volume above normal and directionally bullish
|
On The Fly
|
What has Wall Street been… ShowHide Related Items >><< - $141.70 /
-1.915 (-1.33%) - 01/26/23
- Walmart to open 30 new clubs over next several years
- 01/24/23
- Wal-Mart trading resumes
- 01/24/23
- Wal-Mart trading halted, volatility trading pause
- 01/20/23
- Walmart announces launch of Walmart Business
- 01/31/23
- Uber's Drizly, Gopuff announce partnership for on-demand delivery
- 01/24/23
- Uber trading resumes
- 01/24/23
- Uber trading halted, volatility trading pause
- 12/16/22
- Uber announce new grocery delivery partnership with Meijer
- 01/31/23
- Tesla sees capex of $6.0B-$8.0B in 2023 and $7B-9B in 2024 and 2025
- 01/31/23
- Tesla asked for documents on driver assist systems by DOJ
- 01/25/23
- Tesla extends afterhours gains, up over 5% at $152.45
- 01/25/23
- Tesla CEO says Dojo AI to be competitive with Nvidia at end of 2023
- 01/25/23
- Shopify announces changes to 2023 plan pricing
- 01/24/23
- Shopify trading resumes
- 01/24/23
- Shopify trading halted, volatility trading pause
- 12/29/22
- Bridgeline, Shopify partner for prescriptive marketing dashboard eCommerce360
- 01/31/23
- Amazon Publisher Direct, Paramount Advertising announce expanded agreement
- 01/23/23
- Association of Pickleball Professionals announces broadcast deals with CBS, ESPN
- 12/08/22
- Paramount+ launches in Germany, Switzerland and Austria
- 12/07/22
- Paramount CEO says view of 2023 as peak streaming investment year hasn't changed
- $186.51 /
-2.265 (-1.20%) - 02/01/23
- Meta cuts FY23 total expenses view to $89B-$95B from $94B-$100B
- 02/01/23
- Meta says 2023 will be 'a year of efficiency'
- 02/01/23
- Meta Platforms announces $40B increase in share repurchase authorization
- 02/01/23
- Meta Platforms reports FoA and RL segment restructuring charges
- 02/01/23
- Kroger delivery expands to South Florida
- 12/21/22
- Albertsons says Washington State Supreme Court Set to hear appeal on February 9
- 12/21/22
- Washington state AG files lawsuits against pharmacy chains over opioid crisis
- 12/16/22
- Kroger Health, Prime Therapeutics announce direct agreement, effective January 1
- 11/29/22
- Foot Locker announces leadership team appointments
- 11/18/22
- Foot Locker rises 14.7%
- 11/18/22
- Foot Locker rises 15.8%
- 11/18/22
- Foot Locker says sustained momentum throughout Q3
FBIN Fortune Brands Innovations - 01/23/23
- Fortune Brands Innovations backs prior FY22 EPS view $6.20-$6.30
- 01/23/23
- Stanley Black & Decker names Patrick Hallinan CFO, succeeding Corbin Walburger
- 01/23/23
- Fortune Brands Innovations appoints David Barry CFO. succeeding Hallinan
- 12/19/22
- Fortune Brands Innovations to replace First Solar in S&P 400 at open on 12/19
- 02/02/23
- Ford sees FY23 capital expenditures $8B-$9B
- 02/02/23
- Ford down 6% after Q4 earnings report
- 02/02/23
- Ford declares regular Q1 dividend of 15c, supplemental dividend of 65c
- 02/02/23
- Ford reports January U.S. sales up 2% to 146,356 vehicles
- 12/08/22
- Edwards Lifesciences CEO Michael Mussallem to retire, Bernard Zovighian succeeds
- 11/01/22
- Edwards Lifesciences authorizes $750M accelerated share repurchase
- 10/28/22
- Edwards Lifesciences falls -16.6%
- 10/28/22
- Edwards Lifesciences falls -14.3%
- 02/01/23
- DoorDash, Chegg announce partnership offer
- 01/30/23
- DoorDash announces expected stock sales from co-founders
- 01/17/23
- DoorDash, Starbucks set to expand delivery partnership nationwide
- 12/19/22
- Stitch Fix announces Kofi Amoo-Gottfried joins board
- 01/17/23
- Albertsons says to pay special dividend after Washington Supreme Court ruling
- 01/12/23
- Albertsons and Afresh Technologies roll out AI-powered retail platform
- 01/02/23
- Albertsons granted expedited review of special dividend restraining order
- $186.51 /
-2.265 (-1.20%) - 02/03/23 DA Davidson
- Amazon.com price target raised to $134 from $114 at DA Davidson
- 02/03/23 HSBC
- Meta Platforms downgraded to Reduce from Hold at HSBC
- 02/03/23 DZ Bank
- Meta Platforms upgraded to Hold from Sell at DZ Bank
- 02/02/23 Deutsche Bank
- Meta Platforms price target raised to $200 from $125 at Deutsche Bank
- 01/30/23 Bernstein
- Bernstein sees orders as 'most critical' to Tesla stock
- 01/30/23 Berenberg
- Tesla upgraded to Buy from Hold at Berenberg
- 01/26/23 Morgan Stanley
- Tesla FY23 earnings could bottom near $3 per share, says Morgan Stanley
- 01/26/23 Wedbush
- Tesla price target raised to $200 from $175 at Wedbush
- 02/01/23 Scotiabank
- Scotiabank starts Shopify at Sector Perform on 'robust' valuation
- 02/01/23 Morgan Stanley
- Buy with Prime could be $3.5B-plus EBIT business for Amazon, says Morgan Stanley
- 01/31/23 Scotiabank
- Shopify initiated with a Sector Perform at Scotiabank
- 01/30/23 UBS
- Amazon's Buy with Prime puts up to 14% of Shopify revenue at risk, says UBS
- 01/31/23 Mizuho
- Mizuho 'constructive' on Uber shares into Q4 results
- 01/30/23 MoffettNathanson
- Uber initiated with an Outperform at MoffettNathanson
- 01/26/23 Cowen
- Uber price target lowered to $66 from $70 at Cowen
- 01/24/23 KeyBanc
- KeyBanc upgrades Lyft on 'meaningful opportunity' for EBITDA lift
- 01/30/23 MoffettNathanson
- DoorDash initiated with an Outperform at MoffettNathanson
- 01/09/23 Jefferies
- DoorDash initiated with an Underperform at Jefferies
- 01/09/23 Piper Sandler
- DoorDash downgraded to Underweight from Neutral at Piper Sandler
- 01/09/23 Piper Sandler
- Uber upgraded to Overweight from Neutral at Piper Sandler
- 02/01/23 Credit Suisse
- Foot Locker upgraded to Outperform from Neutral at Credit Suisse
- 11/28/22 Goldman Sachs
- Goldman finds small crowds, more promotions over Black Friday weekend
- 11/21/22 Barclays
- Foot Locker price target raised to $40 from $38 at Barclays
- 11/21/22 Deutsche Bank
- Foot Locker price target raised to $36 from $31 at Deutsche Bank
- 01/30/23 R5 Capital
- R5 double downgrades Kroger to Sell on deteriorating supermarket fundamentals
- 01/30/23 R5 Capital
- Kroger downgraded to Sell from Buy at R5 Capital
- 01/17/23 Morgan Stanley
- Kroger upgraded to Equal Weight from Underweight at Morgan Stanley
- 01/04/23 Wells Fargo
- Kroger price target lowered to $42 from $47 at Wells Fargo
- $141.70 /
-1.915 (-1.33%) - 01/26/23 Tigress Financial
- Walmart upgraded to Buy from Neutral at Tigress Financial
- 01/04/23 Guggenheim
- Roku announces launch of first TV lines, says Guggenheim
- 12/19/22 Credit Suisse
- Walmart assumed with an Outperform at Credit Suisse
- 01/12/23 Deutsche Bank
- Albertsons price target raised to $28 from $27 at Deutsche Bank
- 01/04/23 Wells Fargo
- Albertsons price target lowered to $22 from $30 at Wells Fargo
- 12/19/22 Credit Suisse
- Albertsons assumed with Restricted rating at Credit Suisse
- 01/31/23 Macquarie
- Paramount downgraded to Underperform at Macquarie on high ad exposure
- 01/31/23 Macquarie
- Paramount downgraded to Underperform from Neutral at Macquarie
- 01/12/23 Guggenheim
- Paramount price target raised to $22 from $20 at Guggenheim
- 01/04/23 Macquarie
- Paramount price target lowered to $15 from $16 at Macquarie
- 02/01/23 Canaccord
- Edwards Lifesciences price target raised to $76 from $68 at Canaccord
- 01/31/23 Bernstein
- Edwards Lifesciences downgraded to Underperform from Outperform at Bernstein
- 01/30/23 Piper Sandler
- Edwards Lifesciences downgraded to Neutral from Overweight at Piper Sandler
- 12/12/22 Canaccord
- Edwards Lifesciences price target lowered to $73 from $78 at Canaccord
FBIN Fortune Brands Innovations - 02/02/23 Loop Capital
- Fortune Brands Innovations downgraded to Hold from Buy at Loop Capital
- 02/02/23 Loop Capital
- Fortune Brands Innovations downgraded to Hold from Buy at Loop Capital
- 01/30/23 BofA
- Fortune Brands downgraded to Underperform at BofA on relative valuation
- 01/30/23 BofA
- Fortune Brands Innovations downgraded to Underperform from Neutral at BofA
- 02/03/23 Benchmark
- Ford price target lowered to $19 from $21 at Benchmark
- 02/03/23 Deutsche Bank
- Deutsche downgrades Ford to Sell on 'meaningful' earnings risk
- 02/03/23 Deutsche Bank
- Ford downgraded to Sell from Hold at Deutsche Bank
- 01/25/23 JPMorgan
- Ford price target lowered to $15 from $16 at JPMorgan
- $141.70 /
-1.915 (-1.33%) - 11/15/22
- Walmart raises FY23 adjusted EPS view to down 5%-6% from down 9%-11%
- 11/15/22
- Walmart raises FY23 adjusted EPS view to down 6%-7% from down 9%-11%
- 11/15/22
- Walmart sees Q4 adjusted EPS down 3%-5%, consensus $1.46
- 11/15/22
- Walmart reports Q3 adjusted EPS $1.50, consensus $1.32
- 11/01/22
- Uber reports Q3 EPS (61c), consensus (22c)
- 10/31/22
- Notable companies reporting before tomorrow's open
- 01/25/23
- Tesla reports Q4 EPS $1.19, consensus $1.13
- 01/25/23
- Notable companies reporting after market close
- 10/19/22
- Tesla reports Q3 EPS $1.05, consensus 99c
- 10/19/22
- Notable companies reporting after market close
- 10/27/22
- Shopify reports Q3 adjusted EPS (2c), consensus (10c)
- 10/26/22
- Notable companies reporting before tomorrow's open
- 11/02/22
- Paramount reports Q3 adjusted EPS 39c, consensus 43c
- 11/01/22
- Notable companies reporting before tomorrow's open
- $186.51 /
-2.265 (-1.20%) - 02/01/23
- Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B
- 02/01/23
- Meta Platforms reports Q4 EPS $1.76, consensus $2.22
- 02/01/23
- Notable companies reporting after market close
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- 12/01/22
- Kroger raises FY22 adjusted EPS view to $4.05-$4.15 from $3.95-$4.05
- 12/01/22
- Kroger reports Q3 adjusted EPS 88c, consensus 82c
- 11/30/22
- Notable companies reporting before tomorrow's open
- 11/18/22
- Foot Locker raises FY22 EPS view to $4.42-$4.50 from $4.25-$4.45
- 11/18/22
- Foot Locker sees Q4 EPS 45c-53c, consensus 43c
- 11/18/22
- Foot Locker reports Q3 EPS $1.27, consensus $1.11
- 11/17/22
- Notable companies reporting before tomorrow's open
- 02/02/23
- Ford sees FY23 adjusted EBIT of $9B-$11B
- 02/02/23
- Ford reports Q4 adjusted EPS 51c, consensus 62c
- 02/02/23
- Notable companies reporting after market close
- 10/26/22
- Ford reports Q3 adjusted EPS 39c, consensus 27c
- 01/31/23
- Edwards Lifesciences sees Q1 adjusted EPS 58c-64c, consensus 59c
- 01/31/23
- Edwards Lifesciences backs FY23 adjusted EPS $2.45-$2.60, consensus $2.50
- 01/31/23
- Edwards Lifesciences reports Q4 adjusted EPS 64c, consensus 61c
- 01/31/23
- Notable companies reporting after market close
- 11/03/22
- DoorDash reports Q3 EPS (77c), consensus (60c)
- 11/03/22
- Notable companies reporting after market close
- 08/04/22
- DoorDash sees FY22 adjusted EBITDA of $200M-$500M
- 08/04/22
- DoorDash sees Q3 adjusted EBITDA $25M-$75M
- 01/10/23
- Albertsons reports Q3 adjusted EPS 87c, consensus 67c
- 01/09/23
- Notable companies reporting before tomorrow's open
- 10/18/22
- Albertsons reports Q2 adjusted EPS 72c, consensus 65c
|
Hot Stocks
|
Takeda announced that the… Takeda announced that the U.S. FDA has approved the supplemental Biologics License Application for the expanded use of TAKHZYRO for prophylaxis to prevent attacks of hereditary angioedema in pediatric patients 2 to less than12 years of age. Prior to this approval, the only approved routine prophylaxis treatment options for children 6 to less than12 years of age required dosing every three to four days, and children with HAE 2 to less than 6 years of age had no approved prophylaxis treatment, making TAKHZYRO the first prophylaxis treatment for this age group. The recommended dose is 150 mg/1 mL solution in a single-dose prefilled syringe every four weeks in patients 2 to less than 6 years of age and every two weeks in patients 6 to less than 12 years of age. ShowHide Related Items >><< TAK Takeda Pharmaceutical - 01/23/23
- Hutchmed licenses fruquintinib to Takeda Pharmaceutical for up to $1.13B
- 01/18/23
- Cryoport announces new strategic partnership with Syneos Health
- 01/09/23
- Takeda Pharmaceutical, Arrowhead announce topline results from SEQUOIA study
- 01/05/23
- Takeda Pharmaceutical reports 'favorable' results from Phase 3 TAK-755 trial
TAK Takeda Pharmaceutical - 01/03/23 Wells Fargo
- Ascendis Pharma price target raised to $177 from $169 at Wells Fargo
- 12/13/22 Piper Sandler
- Takeda deal has positive read through for Ventyx, says Piper
- 11/11/22 BTIG
- Poseida Therapeutics price target lowered to $14 from $20 at BTIG
- 10/05/22 H.C. Wainwright
- H.C. Wainwright has more confidence in Astria opportunity after KalVista news
TAK Takeda Pharmaceutical - 08/30/22
- Takeda eyes global vaccine market following Qdenga approval, FT reports
|
Hot Stocks
|
As of January 31, the… As of January 31, the company had 97 active selling communities. ShowHide Related Items >><< - $121.77 /
-2.525 (-2.03%) - 01/31/23
- LGI Homes announces expansion in Fort Myers market with newest community
- 01/05/23
- LGI Homes closes 504 homes in December
- 12/05/22
- LGI Homes announces 412 home closings in November
- 11/03/22
- LGI Homes reports 797 home closings in October
- $121.77 /
-2.525 (-2.03%) - 11/22/22 JPMorgan
- LGI Homes price target raised to $84 from $73 at JPMorgan
- 10/10/22 Wedbush
- LGI Homes price target lowered to $84 from $94 at Wedbush
- 08/03/22 JMP Securities
- LGI Homes price target lowered to $140 from $175 at JMP Securities
- 07/12/22 JPMorgan
- LGI Homes price target lowered to $77 from $85 at JPMorgan
- $121.77 /
-2.525 (-2.03%) - 11/01/22
- LGI Homes reports Q3 EPS $3.85, consensus $3.50
|